European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank

Recruiting now

Conditions studied: Lung Diseases, Interstitial, Pulmonary Alveolar Proteinosis, Pulmonary Eosinophilia, Pulmonary Fibrosis, Respiratory Distress Syndrome, Newborn, Child

In brief

Generation of a common European database and biobank Continous assessment and implementation of guidelines and treatment protocols Establishment of a large observational cohort of chILD patients Determination the value of outcomes used in child Assess treatment variations used, deliver data from defined protocols and linked outcomes

Key facts

Study ID

NCT02852928

Run by

Matthias Griese

People needed

1000

Starts

2013-12-01

Expected to finish

2029-12-01

Last updated by the study team

2022-09-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• all children with suspected or
• verified diagnosis of ILD or
• masquerading as ILD and
• those with rare localized parenchymal lung diseases

You may not qualify if…

• other indication as inclusion criteria

Where it is running

• Medizinische Hochschule Hannover — Hanover, Lower Saxony, Germany (enrolling)
• Hacettepe University, Medical Faculty — Ankara, Sihhiye, Turkey (Türkiye) (enrolling)
• University of Edinburgh — Edinburgh, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.